Location History:
- Portland, OR (US) (2007)
- Portland, CA (US) (2012)
Company Filing History:
2 out of 15,513 
2 out of 509 
Years Active: 2007-2012
Title: Oline K Ronnekleiv: Innovator in Selective Estrogen Receptor Modulators
Introduction
Oline K Ronnekleiv is a prominent inventor based in Portland, CA (US). She has made significant contributions to the field of pharmacology, particularly in the development of selective estrogen receptor modulators (SERMs). With a total of 2 patents, her work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Ronnekleiv's latest patents focus on the development of a new class of selective estrogen receptor modulators. The present disclosure concerns the identification of a previously unknown membrane-associated estrogen receptor. Additionally, the patents include methods for making and using these novel SERMs, along with pharmaceutical formulations that incorporate these compounds in useful compositions.
Career Highlights
Throughout her career, Oline K Ronnekleiv has worked with esteemed institutions such as the University of California and Oregon Health & Science University. Her research has been pivotal in advancing the understanding of estrogen receptors and their modulators.
Collaborations
Some of her notable coworkers include Thomas S Scanlan and Martin J Kelly. Their collaborative efforts have contributed to the innovative research in the field of selective estrogen receptor modulation.
Conclusion
Oline K Ronnekleiv's work in the development of selective estrogen receptor modulators showcases her dedication to advancing medical science. Her contributions are expected to have lasting effects on therapeutic strategies in the future.